African scientists race to test COVID drugs - but face major hurdles

Nature. 2021 Nov;599(7883):25-27. doi: 10.1038/d41586-021-02995-5.
No abstract available

Keywords: Developing world; Medical research; SARS-CoV-2.

MeSH terms

  • Africa
  • Amides
  • Amodiaquine
  • Artesunate
  • Atazanavir Sulfate
  • COVID-19 / physiopathology
  • COVID-19 / prevention & control
  • COVID-19 / transmission
  • COVID-19 Drug Treatment*
  • COVID-19 Vaccines / supply & distribution
  • Carbamates
  • Clinical Trials as Topic / organization & administration
  • Cytidine / analogs & derivatives
  • Cytidine / economics
  • Cytidine / therapeutic use
  • Drug Approval
  • Drug Evaluation, Preclinical*
  • Drug Repositioning
  • Drug Therapy, Combination
  • Humans
  • Hydroxylamines / economics
  • Hydroxylamines / therapeutic use
  • Imidazoles
  • Ivermectin
  • Naphthyridines
  • Nitro Compounds
  • Pregnenediones
  • Pyrazines
  • Pyrrolidines
  • Ritonavir
  • Sample Size
  • Thiazoles
  • Valine / analogs & derivatives
  • World Health Organization

Substances

  • Amides
  • COVID-19 Vaccines
  • Carbamates
  • Hydroxylamines
  • Imidazoles
  • Naphthyridines
  • Nitro Compounds
  • Pregnenediones
  • Pyrazines
  • Pyrrolidines
  • Thiazoles
  • Amodiaquine
  • Atazanavir Sulfate
  • Cytidine
  • Artesunate
  • Ivermectin
  • favipiravir
  • Valine
  • daclatasvir
  • Ritonavir
  • ciclesonide
  • nitazoxanide
  • pyronaridine
  • molnupiravir